Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 395351000001111 | Mogamulizumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 395361000001114 | Mogamulizumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mogamulizumab | Is a | Monoclonal antibody | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mogamulizumab 20mg/5ml solution for infusion vials 1 vial | Has specific active ingredient | False | Mogamulizumab | Inferred relationship | Existential restriction modifier | |
| Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) 1 vial | Has specific active ingredient | False | Mogamulizumab | Inferred relationship | Existential restriction modifier | |
| Poteligeo 20mg/5ml concentrate for solution for infusion vials (Kyowa Kirin Ltd) | Has specific active ingredient | False | Mogamulizumab | Inferred relationship | Existential restriction modifier | |
| Mogamulizumab 20mg/5ml solution for infusion vials | Has specific active ingredient | False | Mogamulizumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR